The Use of Plasma Volume Calculations to Manage Acute Heart Failure: History, Current Status, and Future Directions

Main Article Content

Dennis G. Begos, MD, FACS

Abstract

The use of calculated formulas for plasma volume based on hemoglobin and hematocrit (H&H) and other physiologic parameters is being increasingly used to gauge prognosis in patients with heart failure.


 


Many formulas exist, but they can be simplified into those which rely solely on H&H, and others which rely on H&H plus parameters such as weight and sex. The formulas that rely solely on H&H are the Strauss and Duarte formulas, while those which incorporate other parameters include the Hakim and Kaplan formulas.


 


There is now a large body of evidence that demonstrates these simple formulas can convey prognosis and may be valuable as a prospective measurement to guide therapy.


 


This review lays out the evidence for using plasma volume calculations in patients with heart failure and the benefits that can be derived from utilizing them in the management of heart failure.

Keywords: Plasma Volume Calculations, Acute Heart Failure, Heart Failure

Article Details

How to Cite
BEGOS, Dennis G.. The Use of Plasma Volume Calculations to Manage Acute Heart Failure: History, Current Status, and Future Directions. Medical Research Archives, [S.l.], v. 12, n. 1, jan. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5004>. Date accessed: 03 mar. 2024. doi: https://doi.org/10.18103/mra.v12i1.5004.
Section
Research Articles

References

1. Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118:3272-3287. doi: 10.1093/cvr/cvac013

2. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143:e254-e743. doi: 10.1161/CIR.0000000000000950

3. Wideqvist M, Cui X, Magnusson C, Schaufelberger M, Fu M. Hospital readmissions of patients with heart failure from real world: timing and associated risk factors. ESC Heart Failure. 2021;8:1388-1397. doi: 10.1002/ehf2.13221

4. Lawson C, Crothers H, Remsing S, Squire I, Zaccardi F, Davies M, Bernhardt L, Reeves K, Lilford R, Khunti K. Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity. eClinicalMedicine. 2021;38:101008. doi: 10.1016/j.eclinm.2021.101008

5. Foroutan F, Rayner DG, Ross HJ, Ehler T, Srivastava A, Shin S, Malik A, Benipal H, Yu C, Lau THA, et al. Global Comparison of Readmission Rates for Patients With Heart Failure. Journal of the American College of Cardiology. 2023;82:430-444. doi: doi:10. 1016/j.jacc.2023.05.040

6. Khan MS, Sreenivasan J, Lateef N, Abougergi MS, Greene SJ, Ahmad T, Anker SD, Fonarow GC, Butler J. Trends in 30- and 90-Day Readmission Rates for Heart Failure. Circulation: Heart Failure. 2021;14. doi: 10.1161/circheartfailure.121.008335

7. Strauss MB, Davis RK, Rosenbaum JD, Rossmeisl EC. Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution. J Clin Invest. 1951; 30:862-868. doi: 10.1172/JCI102501

8. Ismail N, Neyra, R, Hakim, RM. Plasmapheresis. In: John T. Daugirdas PGB, Todd S. Ing ed. Handbook of Dialysis. Philadelphia: Lippincott, Williams and Wilkins; 2001:231-262.

9. Kaplan AA. A simple and accurate method for prescribing plasma exchange. ASAIO Trans. 1990;36:M597-599.

10. Duarte K, Monnez JM, Albuisson E, Pitt B, Zannad F, Rossignol P. Prognostic Value of Estimated Plasma Volume in Heart Failure. JACC Heart Fail. 2015;3:886-893. doi: 10.1016/j.jchf.2015.06.014

11. Ling HZ, Flint J, Damgaard M, Bonfils PK, Cheng AS, Aggarwal S, Velmurugan S, Mendonca M, Rashid M, Kang S, et al. Calculated plasma volume status and prognosis in chronic heart failure. Eur J Heart Fail. 2015;17:35-43. doi: 10.1002/ejhf.193

12. Bilchick KC, Chishinga N, Parker AM, Zhuo DX, Rosner MH, Smith LA, Mwansa H, Blackwell JN, McCullough PA, Mazimba S. Plasma Volume and Renal Function Predict Six-Month Survival after Hospitalization for Acute Decompensated Heart Failure. Cardiorenal Med. 2017;8:61-70. doi: 10.1159/ 000481149

13. Balderston JR, Shah KB, Paciulli SC, Gertz ZM. Usefulness of Estimated Plasma Volume at Postdischarge Follow-Up to Predict Recurrent Events in Patients With Heart Failure. Am J Cardiol. 2018;122:1191-1194. doi: 10.1016/j.amjcard.2018.06.057

14. Huang CY, Lin TT, Wu YF, Chiang FT, Wu CK. Long-term Prognostic Value of Estimated Plasma Volume in Heart Failure with Preserved Ejection Fraction. Scientific reports. 2019;9:14369. doi: 10.1038/s41598-019-50427-2

15. Kobayashi M, Rossignol P, Ferreira JP, Aragao I, Paku Y, Iwasaki Y, Watanabe M, Fudim M, Duarte K, Zannad F, et al. Prognostic value of estimated plasma volume in acute heart failure in three cohort studies. Clin Res Cardiol. 2019;108:549-561. doi: 10.1007/s00392-018-1385-1

16. Tamaki S, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Seo M, Abe M, et al. Prognostic Value of Calculated Plasma Volume Status in Patients Admitted for Acute Decompensated Heart Failure- A Prospective Comparative Study With Other Indices of Plasma Volume. Circ Rep. 2019;1:361-371. doi: 10.1253/circrep. CR-19-0039

17. Grodin JL, Philips S, Mullens W, Nijst P, Martens P, Fang JC, Drazner MH, Tang WHW, Pandey A. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT. European Journal of Heart Failure. 2019;21:634-642. doi: 10.1002/ejhf.1407

18. Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, et al. Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial. Circulation. 2015;131:34-42. doi: 10.1161/circulationaha.114.013255

19. Kobayashi M, Girerd N, Duarte K, Preud'homme G, Pitt B, Rossignol P. Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction. Clin Res Cardiol. 2020. doi: 10.1007/s00392-020-01639-4

20. Lin Y, Xue Y, Liu J, Wang X, Wei L, Bai L, Ma A. Prognostic value of estimated plasma volume in patients with chronic systolic heart failure. J Investig Med. 2020. doi: 10.1136/ jim-2020-001538

21. Kobayashi M, Douair A, Coiro S, Giacomin G, Bassand A, Jaeger D, Duarte K, Huttin O, Zannad F, Rossignol P, et al. A Combination of Chest Radiography and Estimated Plasma Volume May Predict In-Hospital Mortality in Acute Heart Failure. Front Cardiovasc Med. 2021;8:752915. doi: 10.3389/fcvm.2021.752915

22. Swolinsky JS, Tuvshinbat E, Leistner DM, Edelmann F, Knebel F, Nerger NP, Lemke C, Roehle R, Haase M, Costanzo MR, et al. Discordance between estimated and measured changes in plasma volume among patients with acute heart failure. ESC Heart Failure. 2021;n/a. doi: https://doi.org/10.1002/ehf2.13739

23. Begos D, Milojkovic B. Letter to the editor regarding ‘Discordance between estimated and measured changes in plasma volume among patients with acute heart failure’. ESC Heart Failure. 2022;n/a. doi: https://doi.org/10.1002/ehf2.13874

24. Cuthbert JJ, Pellicori P, Rigby AS, Abel AAI, Kalvickbacka-Bennet A, Shah P, Kearsley JW, Kazmi S, Cleland JGF, Clark AL. Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure? Eur Heart J Qual Care Clin Outcomes. 2022. doi: 10.1093/ ehjqcco/qcac035

25. Leahova-Cerchez X, Berthelot E, Genet B, Hanon O, Jourdain P. Estimation of the plasma volume status of elderly patients with acute decompensated heart failure using bedside clinical, biological, and ultrasound parameters. Clin Cardiol. 2022;45:379-385. doi: 10.1002/clc.23791

26. Soetjoadi H, Friska D, Siswanto BB, Muliawan HS. Impact of Estimated Plasma Volume Status on Mortality in Right Heart Failure Patients: A Retrospective Cohort Study in Indonesia. Glob Heart. 2022;17:60. doi: 10.5334/gh.1136

27. Çetin Güvenç R, Güvenç TS, Akıl MA, Bekar L, Vural MG, Yılmaz MB. Estimated plasma volume is not a robust indicator of the severity of congestion in patients with heart failure. Am J Med Sci. 2023;366:374-382. doi: 10.1016/j.amjms.2023.08.008

28. Chen X, Lin G, Dai C, Xu K. Effect of estimated plasma volume status and left atrial diameter on prognosis of patients with acute heart failure. Front Cardiovasc Med. 2023;10: 1069864. doi: 10.3389/fcvm.2023.1069864

29. Nogi K, Ueda T, Nakamura T, Nogi M, Ishihara S, Nakada Y, Hashimoto Y, Nakagawa H, Nishida T, Seno A, et al. New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure. Journal of the American Heart Association. 2023;12. doi: 10.1161/jaha.122. 025596

30. Wu Y, Tian P, Liang L, Chen Y, Feng J, Huang B, Huang L, Zhao X, Wang J, Guan J, et al. Estimated plasma volume status adds prognostic value to hemodynamic parameters in advanced heart failure. Intern Emerg Med. 2023;18:2281-2291. doi: 10.1007/s11739-023 -03422-5

31. Rao M. Bedside Prognostication in Decompensated Heart Failure: No “Easy Button”. Journal of the American Heart Association. 2023;12. doi: 10.1161/jaha.122. 028500

32. Jankowska EA, Andersson T, Kaiser‐Albers C, Bozkurt B, Chioncel O, Coats AJS, Hill L, Koehler F, Lund LH, Mcdonagh T, et al. Optimizing outcomes in heart failure: 2022 and beyond. ESC Heart Failure. 2023. doi: 10.1002/ehf2.14363

33. News P. Nova blood gas analysers add important new test – estimated plasma volume. Clinical Laboratory International. 2020.

34. Miller WL, Grill DE, Mullan BP. Differences in red blood cell mass profiles impact intravascular volume and outcome risk in chronic heart failure. ESC Heart Failure. 2023;10:1270-1279. doi: 10.1002/ehf2.14309

35. Yogeswaran A, Richter MJ, Husain-Syed F, Rako Z, Sommer N, Grimminger F, Seeger W, Ghofrani HA, Gall H, Tello K. Estimated plasma volume status: association with congestion, cardiorenal syndrome and prognosis in precapillary pulmonary hypertension. Front Cardiovasc Med. 2023; 10:1161041. doi: 10.3389/fcvm.2023.1161041

36. Sternberg ME, Grinnan D, Gertz ZM. Utility of plasma volume status in ambulatory patients with pulmonary hypertension. Pulm Circ. 2022;12:e12045. doi: 10.1002/pul2.12045

37. Miyoshi T. Estimated plasma volume status as a prognostic marker in patients with lower extremity artery disease. Hypertension Research. 2023. doi: 10.1038/s41440-023-01383-y

38. Kurokawa T, Otaki Y, Takahashi H, Watanabe T, Shikama T, Tamura H, Kato S, Nishiyama S, Arimoto T, Watanabe M. Impact of estimated plasma volume status on clinical outcomes in patients with lower extremity artery disease who underwent endovascular therapy. Hypertens Res. 2023;46:2005-2015. doi: 10.1038/s41440-023-01315-w

39. Krečak I, Nižetić K, Čeko M, Skelin M, Lucijanić M. Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism. Int J Lab Hematol. 2023;45:e32-e35. doi: 10.1111/ijlh.13982

40. Shimura T, Yamamoto M, Yamaguchi R, Adachi Y, Sago M, Tsunaki T, Kagase A, Koyama Y, Otsuka T, Yashima F, et al. Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement. ESC Heart Fail. 2021. doi: 10.1002/ehf2.13270

41. Seoudy H, Saad M, Salem M, Allouch K, Frank J, Puehler T, Salem M, Lutter G, Kuhn C, Frank D. Calculated Plasma Volume Status Is Associated with Adverse Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation. Journal of Clinical Medicine. 2021;10:3333.

42. Maznyczka AM, Barakat M, Aldalati O, Eskandari M, Wollaston A, Tzalamouras V, Dworakowski R, Deshpande R, Monaghan M, Byrne J, et al. Calculated plasma volume status predicts outcomes after transcatheter aortic valve implantation. Open Heart. 2020;7. doi: 10.1136/openhrt-2020-001477

43. Chen J, Shen J, Cai D, Wei T, Qian R, Zeng C, Lyu L. Estimated plasma volume status (ePVS) is a predictor for acute myocardial infarction in-hospital mortality: analysis based on MIMIC-III database. BMC Cardiovasc Disord. 2021;21:530. doi: 10.1186/s12872-021-02338-2

44. Ramos-Gordillo JM, Pérez-Campuzano C, Relles-Andrade E, Peña-Rodríguez JC. The role of plasma volume and fluid overload in the tolerance to ultrafiltration and hypotension in hemodialysis patients. Renal failure. 2023;45. doi: 10.1080/0886022x. 2022.2151917

45. Balasubramanian P, Isha S, Hanson AJ, Jenkins A, Satashia P, Balavenkataraman A, Huespe IA, Bansal V, Caples SM, Khan SA, et al. Association of plasma volume status with outcomes in hospitalized Covid-19 ARDS patients: A retrospective multicenter observational study. Journal of critical care. 2023;78:154378. doi:https://doi.org/10.1016/j.jcrc.2023.154378

46. Lucijanic M, Krecak I, Busic I, Atic A, Stojic J, Sabljic A, Soric E, Veic P, Marevic S, Derek L, et al. Estimated plasma volume status in COVID-19 patients and its relation to comorbidities and clinical outcomes. J Thromb Thrombolysis. 2023. doi: 10.1007/ s11239-023-02882-y

47. Svensson R, Hahn RG, Zdolsek JH, Bahlmann H. Plasma volume expansion reveals hidden metabolic acidosis in patients with diabetic ketoacidosis. Intensive Care Med Exp. 2022;10:36. doi: 10.1186/s40635-022-00464-5

48. Lucijanic M, Krecak I, Soric E, Sabljic A, Galusic D, Holik H, Perisa V, Peric MM, Zekanovic I, Kusec R. MPN-541 Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks. Clin Lymphoma Myeloma Leuk. 2022;22 Suppl 2:S341-s342. doi: 10.1016/s2152-2650(22)01467-7

49. Kim KH, Cho HJ, Kim SC, Lee J. Prognostic Value of Estimated Plasma Volume Status in Patients With Sepsis. J Korean Med Sci. 2022;37.

50. Turcato G, Zaboli A, Ciccariello L, Pfeifer N. Estimated plasma volume status (ePVS) could be an easy-to-use clinical tool to determine the risk of sepsis or death in patients with fever. Journal of critical care. 2020;58:106-112. doi: 10.1016/j.jcrc.2020.05.001

51. Krecak I, Zekanovic I, Holik H, Moric Peric M, Coha B, Gveric-Krecak V. Estimating plasma volume using the Strauss-derived formula may improve prognostication in polycythemia vera. Int J Lab Hematol. 2021. doi: 10.1111/ijlh.13716

52. Niedermeyer SE, Stephens RS, Kim BS, Metkus TS. Calculated Plasma Volume Status Is Associated With Mortality in Acute Respiratory Distress Syndrome. Crit Care Explor. 2021;3:e0534. doi: 10.1097/cce.0000 000000000534

53. Otaki Y, Watanabe T, Konta T, Watanabe M, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, et al. One-year change in plasma volume and mortality in the Japanese general population: An observational cohort study. PloS one. 2021;16:e0254665. doi: 10.1371/journal.pone.0254665

54. Marawan A, Qayyum R. Estimated plasma volume and mortality: analysis from NHANES 1999-2014. Clin Res Cardiol. 2020;109:1148-1154. doi: 10.1007/s00392-020-01606-z